Legal Representation
Attorney
Matthew A. Homyk
USPTO Deadlines
Next Deadline
563 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20210810)
Due Date
August 10, 2027
Grace Period Ends
February 10, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
34 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 10, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jul 7, 2021 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Jul 6, 2021 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jun 5, 2021 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Jun 3, 2021 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jun 3, 2021 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jan 9, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 7, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jan 7, 2021 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jan 7, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 19, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 19, 2020 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
| Aug 18, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 7, 2020 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Aug 18, 2020 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Jul 7, 2020 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Aug 3, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jul 7, 2020 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Jul 7, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 7, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 12, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 12, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 23, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 3, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 27, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 27, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Sep 27, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 27, 2019 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 27, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Sep 25, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 19, 2019 | TAEA | I | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | Loading... |
| Jul 19, 2019 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Jul 16, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 12, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Full line of neurological, central nervous system, anti-inflammatory, cardiovascular, renal, anti-microbial, anti-neoplastic, immunomodulatory, hematopoietic, anticoagulant, thrombolytic, antiplatelet, estrogenic, progestin, androgen, thyroid, anti-thyroid, ophthalmic, histamine H2 receptor antagonist, proton pump antagonist, anti-emetic, anti-convulsant, anti-asthmatic and anti-diabetic pharmaceutical preparations
First Use Anywhere:
Jan 29, 2020
First Use in Commerce:
Jan 29, 2020
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS LABS INC."